Literature DB >> 19773709

Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder.

Mu-En Liu, Shih-Jen Tsai, Szu-Tung Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19773709     DOI： 10.1017/s1092852900022975

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  5 in total

1.  Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.

Authors:  Sungwon Roh; Susanne S Hoeppner; David Schoenfeld; Catherine A Fullerton; Luke E Stoeckel; A Eden Evins
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

2.  Late-life Onset Mania After Varenicline Use: A Case Report.

Authors:  Abdullah Akpinar; Gülin Özdamar Ünal; İnci Meltem Atay; Duru Gündoğar; Ramazan Özçankaya
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

3.  A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.

Authors:  Mahtab Karkhane Yousefi; Timothy D Folsom; S Hossein Fatemi
Journal:  J Addict Res Ther       Date:  2011-12-20

Review 4.  Interventions for smoking cessation and reduction in individuals with schizophrenia.

Authors:  Daniel T Tsoi; Mamta Porwal; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

5.  N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial.

Authors:  Lauren Arancini; Chiara C Bortolasci; Seetal Dodd; Olivia M Dean; Michael Berk
Journal:  Trials       Date:  2019-09-10       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.